Loading... Please wait... Loading... Please wait...
ESTIMATED
08/15/2023
08/15/2023
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.57 | $1.57 | $1.57 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Qualigen Therapeutics, Inc. last posted its earnings results on Tuesday, August 15th, 2023. The company reported $-0.69 earnings per share for the quarter, missing analysts' consensus estimates of $-0.52 by $0.17. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Qualigen Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.53 diluted earnings per share) and currently has a price-to-earnings ratio of -0.06. Qualigen Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 2nd, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 12/29/2023 | Q4 2023 | -$0.47 | $0 | $0 | 11/14/2023 | Q3 2023 | -$0.72 | $500,000 | $7.94 M | 08/14/2023 | Q2 2023 | -$0.69 | $1.60 M | $1.63 M | 05/15/2023 | Q1 2023 | -$0.83 | $1.40 M | $1.61 M | 05/02/2023 | Q4 2022 | -$2.03 | $1.50 M | $1.39 M | 11/14/2022 | Q3 2022 | -$0.97 | $1.62 M | $1.44 M | 08/15/2022 | Q2 2022 | -$1.13 | $1.20 M | $1.43 M | 05/13/2022 | Q1 2022 | -$1.70 | -$1.22 | 0.48 | $722,029 | 03/31/2022 | Q4 2021 | -$1.70 | -$1.94 | -0.24 | $1.32 M | $1.48 M | 11/15/2021 | Q3 2021 | -$2.10 | -$0.98 | 1.12 | $1.34 M | $1.16 M | 08/16/2021 | Q2 2021 | -$1.84 | $1.70 M | $1.12 M | 05/14/2021 | Q1 2021 | -$1.60 | -$1.33 | 0.27 | $1.90 M | 11/12/2020 | Q3 2020 | -$4.10 | $1.58 M | $837,714 | 08/14/2020 | Q2 2020 | -$21.24 | $904,067 | 05/01/2020 | Q1 2020 | -$2.98 | $0 | 03/31/2020 | Q4 2019 | -$15.00 | -$10,588,244.32 | -10588229.32 | $-2,711,962 | 11/13/2019 | Q3 2019 | -$57.50 | -$0.64 | 56.86 | $1.20 M | $1.20 M | 08/14/2019 | Q2 2019 | -$122.50 | -$0.95 | 121.55 | $2.07 M | $1.51 M | 05/15/2019 | Q1 2019 | -$181.25 | -$8.40 | 172.85 | $0 | 04/01/2019 | Q4 2018 | -$12.49 | $0 |
|---|
A. Qualigen Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 2nd, 2024 based off last year's report dates.
A. The conference call for Qualigen Therapeutics, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Qualigen Therapeutics, Inc.'s latest earnings report can be read online.
A. Qualigen Therapeutics, Inc. (NASDAQ:QLGN) has a recorded net income of $0. Qualigen Therapeutics, Inc. has generated $-2.53 earnings per share over the last four quarters.
A. Qualigen Therapeutics, Inc. (NASDAQ:QLGN) has a price-to-earnings ratio of -0.06 and price/earnings-to-growth ratio is -0.
